Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Cooper

Showing results (181-190 of 399) with videos related to

Pageof 40
Sort By:
The American Journal of Pathology|March 25, 2004
Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathwayJin H Li, Wansheng Wang, Xiao R Huang, et al.
Journal of the American Society of Nephrology : JASN|July 31, 2004
Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathyFiona T H Lee, Zemin Cao, David M Long, et al.
Endocrinology|November 26, 2002
Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidineStephen M Twigg, Zemin Cao, Sue V MCLennan, et al.
Diabetes Care|March 29, 2002
A low-sodium diet potentiates the effects of losartan in type 2 diabetesChristine A Houlihan, Terri J Allen, Amynta L Baxter, et al.
Diabetes, Obesity & Metabolism|November 21, 2024
The prognostic impact of the Stress Hyperglycemia Ratio on End-Stage Renal Disease among patients with Diabetic Kidney DiseaseYutong Zou, Qing Yang, Yanlin Lang, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2003
Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathyChristos Tikellis, Colin I Johnston, Josephine M Forbes, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetesJosephine M Forbes, Vicki Thallas, Merlin C Thomas, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 5, 2019
Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical OutcomesToshiaki Ohkuma, Min Jun, John Chalmers, et al.
Diabetes|October 29, 2002
ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 ratJennifer L Wilkinson-Berka, Darren J Kelly, Suzanne M Koerner, et al.
JACC. Advances|November 8, 2025
Effect of Empagliflozin on Whole Body, Cardiac, and Renal Sympathetic Outflows in Type 2 DiabetesAnne T Reutens, Dulari Hakamuwa Lekamlage, Agus Salim, et al.
Pageof 40

Showing results (181-190 of 399) with videos related to

Sort By:
Pageof 40
The American Journal of Pathology|March 25, 2004
Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathwayJin H Li, Wansheng Wang, Xiao R Huang, et al.
Journal of the American Society of Nephrology : JASN|July 31, 2004
Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathyFiona T H Lee, Zemin Cao, David M Long, et al.
Endocrinology|November 26, 2002
Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidineStephen M Twigg, Zemin Cao, Sue V MCLennan, et al.
Diabetes Care|March 29, 2002
A low-sodium diet potentiates the effects of losartan in type 2 diabetesChristine A Houlihan, Terri J Allen, Amynta L Baxter, et al.
Diabetes, Obesity & Metabolism|November 21, 2024
The prognostic impact of the Stress Hyperglycemia Ratio on End-Stage Renal Disease among patients with Diabetic Kidney DiseaseYutong Zou, Qing Yang, Yanlin Lang, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2003
Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathyChristos Tikellis, Colin I Johnston, Josephine M Forbes, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetesJosephine M Forbes, Vicki Thallas, Merlin C Thomas, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 5, 2019
Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical OutcomesToshiaki Ohkuma, Min Jun, John Chalmers, et al.
Diabetes|October 29, 2002
ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 ratJennifer L Wilkinson-Berka, Darren J Kelly, Suzanne M Koerner, et al.
JACC. Advances|November 8, 2025
Effect of Empagliflozin on Whole Body, Cardiac, and Renal Sympathetic Outflows in Type 2 DiabetesAnne T Reutens, Dulari Hakamuwa Lekamlage, Agus Salim, et al.
Pageof 40